Biblio
Export 2 results:
[ Author] Title Type Year Filters: First Letter Of Last Name is F and Author is Franzini, Anca [Clear All Filters]
Gene expression signatures predictive of bevacizumab/erlotinib therapeutic benefit in advanced non-squamous non-small cell lung cancer patients (SAKK 19/05 trial).
Clinical Cancer Research. clincanres––3135.
(2015). Tumor-associated stromal gene expression signatures predict therapeutic response to erlotinib/bevacizumab in non-small cell lung cancer (NSCLC).
European Respiratory Journal. 44, P821.
(2014).